Larotrectinib sulfate
Definition: Larotrectinib, sold under the brand name Vitrakvi, is a medication for the treatment of cancer. It is an inhibitor of tropomyosin kinase receptors TrkA, TrkB, and TrkC. It was discovered by Array BioPharma and licensed to Loxo Oncology in 2013. source: Wikipedia
- ID
- 1217200005
- ID date
- 6 Dec 2022
- Previous ID
- 37752311000001107
- Name
- Larotrectinib sulfate